ATE250628T1 - Rohr bestehend aus zyklischen peptiden - Google Patents

Rohr bestehend aus zyklischen peptiden

Info

Publication number: ATE250628T1
Authority: AT; Austria
Prior art keywords: molecular; cyclic; channel; tubes; cyclic peptide
Prior art date: 1993-10-14

Application number

AT94930755T

Other languages

English (en)

Inventor

Reza M Ghadiri

Original Assignee

Scripps Research Inst

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-10-14

Filing date

1994-10-14

Publication date

2003-10-15

1994-10-14 Application filed by Scripps Research Inst filed Critical Scripps Research Inst

2003-10-15 Application granted granted Critical

2003-10-15 Publication of ATE250628T1 publication Critical patent/ATE250628T1/de

Links

102000001189 Cyclic Peptides Human genes 0.000 title abstract 8
108010069514 Cyclic Peptides Proteins 0.000 title abstract 8
108091006146 Channels Proteins 0.000 abstract 4
125000000539 amino acid group Chemical group 0.000 abstract 2
125000003277 amino group Chemical group 0.000 abstract 2
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
108090000862 Ion Channels Proteins 0.000 abstract 1
102000004310 Ion Channels Human genes 0.000 abstract 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 1
239000004472 Lysine Substances 0.000 abstract 1
125000003275 alpha amino acid group Chemical group 0.000 abstract 1
230000015572 biosynthetic process Effects 0.000 abstract 1
125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 abstract 1
125000004122 cyclic group Chemical group 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
235000013922 glutamic acid Nutrition 0.000 abstract 1
239000004220 glutamic acid Substances 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
230000002209 hydrophobic effect Effects 0.000 abstract 1
150000002632 lipids Chemical class 0.000 abstract 1
239000012528 membrane Substances 0.000 abstract 1
239000002808 molecular sieve Substances 0.000 abstract 1
102000004196 processed proteins & peptides Human genes 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)

AT94930755T 1993-10-14 1994-10-14 Rohr bestehend aus zyklischen peptiden ATE250628T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US13850293A	1993-10-14	1993-10-14
US32092294A	1994-10-11	1994-10-11
PCT/US1994/011620 WO1995010535A1 (en)	1993-10-14	1994-10-14	Cyclic peptide tube

Publications (1)

Publication Number	Publication Date
ATE250628T1 true ATE250628T1 (de)	2003-10-15

Family

ID=26836263

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT94930755T ATE250628T1 (de)	1993-10-14	1994-10-14	Rohr bestehend aus zyklischen peptiden

Country Status (7)

Country	Link
US (1)	US6613875B1 (de)
EP (1)	EP0723554B1 (de)
AT (1)	ATE250628T1 (de)
AU (1)	AU7978194A (de)
DE (1)	DE69433178T2 (de)
DK (1)	DK0723554T3 (de)
WO (1)	WO1995010535A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9506806D0 (en) *	1995-04-01	1995-05-24	Univ Leeds	Improvements relating to polymers
US6740409B1 (en) *	2000-11-15	2004-05-25	Board Of Trustees Of University Of Illinois	Polymer films
AU2002246302A1 (en) *	2001-03-23	2002-10-08	University College Dublin	Macrocyclic oligosaccharide derivatives which form manoscale assemblies
EP1402001A4 (de) *	2001-05-04	2006-05-24	Scripps Research Inst	Antimikrobielle peptide und zusammensetzungen
US7133725B2 (en) *	2001-12-19	2006-11-07	Wilk Patent Development Corporation	Method and related composition employing nanostructures
US20040052928A1 (en) *	2002-09-06	2004-03-18	Ehud Gazit	Peptides and methods using same for diagnosing and treating amyloid-associated diseases
US7781396B2 (en) *	2002-01-31	2010-08-24	Tel Aviv University Future Technology Development L.P.	Peptides directed for diagnosis and treatment of amyloid-associated disease
AU2003228896A1 (en) *	2002-05-06	2003-11-17	The Scripps Research Institute	Anti-microbial peptides and compositions
US7355216B2 (en) *	2002-12-09	2008-04-08	The Regents Of The University Of California	Fluidic nanotubes and devices
US7491699B2 (en)	2002-12-09	2009-02-17	Ramot At Tel Aviv University Ltd.	Peptide nanostructures and methods of generating and using the same
US7898005B2 (en) *	2002-12-09	2011-03-01	The Regents Of The University Of California	Inorganic nanotubes and electro-fluidic devices fabricated therefrom
EP1583713B1 (de) *	2003-01-07	2009-03-25	Ramot at Tel Aviv University Ltd.	Peptidenanostrukturen die fremdmaterial enthalten, und verfahren zur herstellung derselben
FR2853657B1 (fr) *	2003-04-10	2005-06-24	Centre Nat Rech Scient	Macromolecules auto assemblees et photopolymerisees autour de nanotubes de carbone, un procede pour leur preparation, et leurs applications
WO2005069750A2 (en) *	2003-06-18	2005-08-04	Hemolytics, Inc.	Therapeutic composition with nanoscale activation agents
CN101415724B (zh) *	2003-06-30	2015-12-02	特拉维夫大学未来科技开发有限公司	肽、抗肽抗体以及用它们来诊断和治疗淀粉样蛋白相关疾病的方法
WO2005027901A1 (en) *	2003-09-25	2005-03-31	Tel Aviv University Future Technology Development L.P.	Compositions and methods using same for treating amyloid-associated diseases
WO2005031362A2 (en) *	2003-10-02	2005-04-07	Ramot At Tel Aviv University Ltd.	Novel antibacterial agents and methods of identifying and utilizing same
US20090156471A1 (en) *	2004-07-15	2009-06-18	Ramot At Tel Aviv University Ltd.	Use of anti-amyloid agents for treating and typing pathogen infections
WO2006013552A2 (en)	2004-08-02	2006-02-09	Ramot At Tel Aviv University Ltd.	Articles of peptide nanostructures and method of forming the same
US7732479B2 (en) *	2004-08-19	2010-06-08	Tel Aviv University Future Technology Development L.P.	Compositions for treating amyloid associated diseases
US7786086B2 (en) *	2004-09-08	2010-08-31	Ramot At Tel-Aviv University Ltd.	Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
US7459013B2 (en) *	2004-11-19	2008-12-02	International Business Machines Corporation	Chemical and particulate filters containing chemically modified carbon nanotube structures
US7544978B2 (en) *	2005-01-24	2009-06-09	Lawrence Livermore National Security, Llc	Lipid nanotube or nanowire sensor
EP1879600B1 (de) *	2005-05-06	2012-11-21	The University of Kentucky Research Foundation	Nanoröhrchen als mitochondrienentkoppler
EP1973928A2 (de) *	2005-10-11	2008-10-01	Ramot at Tel-Aviv University Ltd.	Selbstzusammengebaute fmoc-ff-hydrogele
US7879212B2 (en) *	2005-11-03	2011-02-01	Ramot At Tel-Aviv University Ltd.	Peptide nanostructure-coated electrodes
WO2007120728A2 (en) *	2006-04-11	2007-10-25	Mathconsult Gmbh	Mathematical design of ion channel selectivity via inverse problems technology
US20110177154A1 (en) *	2008-09-15	2011-07-21	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Tubular nanostructure targeted to cell membrane
US8975368B2 (en) *	2009-08-13	2015-03-10	The United States Of America, As Represented By The Secretary Of The Navy	Methods for preparing linked peptide rings and peptide nanotubes obtained thereby
JP2021103942A (ja) *	2018-04-16	2021-07-26	Jsr株式会社	イムノグロブリン結合性ポリペプチド、及びそれを用いたアフィニティー担体
CN114249295B (zh) *	2020-09-25	2023-04-18	中国科学院理化技术研究所	一种通过共价键或配位键合成的一维有机纳米管及方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4102877A (en)	1976-07-28	1978-07-25	Merck & Co., Inc.	Cyclization of peptides
CA1101843A (en)	1976-08-02	1981-05-26	Daniel F. Veber	Cyclic hexapeptides useful for increasing feed efficiency
EP0284898A3 (de)	1987-04-02	1990-06-27	Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.	Hinge-Peptid, Verfahren zu seiner Herstellung und seine Verwendung zur Herstellung synthetischer Immunogene
US5169862A (en)	1989-07-07	1992-12-08	Peptide Technologies Corporation	Analogs of viscosin and their uses
US5225528A (en)	1990-02-27	1993-07-06	Merck & Co., Inc.	Cyclic hexapeptide oxytocin antagonists

1994
- 1994-10-14 AT AT94930755T patent/ATE250628T1/de not_active IP Right Cessation
- 1994-10-14 AU AU79781/94A patent/AU7978194A/en not_active Abandoned
- 1994-10-14 DK DK94930755T patent/DK0723554T3/da active
- 1994-10-14 US US08/632,444 patent/US6613875B1/en not_active Expired - Fee Related
- 1994-10-14 WO PCT/US1994/011620 patent/WO1995010535A1/en not_active Ceased
- 1994-10-14 EP EP94930755A patent/EP0723554B1/de not_active Expired - Lifetime
- 1994-10-14 DE DE69433178T patent/DE69433178T2/de not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE69433178T2 (de)	2004-06-17
DE69433178D1 (de)	2003-10-30
DK0723554T3 (da)	2004-02-02
US6613875B1 (en)	2003-09-02
WO1995010535A1 (en)	1995-04-20
AU7978194A (en)	1995-05-04
EP0723554B1 (de)	2003-09-24
EP0723554A1 (de)	1996-07-31

Similar Documents

Publication	Publication Date	Title
DE69433178D1 (de)	2003-10-30	Rohr bestehend aus zyklischen peptiden
Hamann et al.	1993	Kahalalide F: a bioactive depsipeptide from the sacoglossan mollusk Elysia rufescens and the green alga Bryopsis sp
Lipmann	1981	Bacterial production of antibiotic polypeptides by thiol-linked synthesis on protein templates
EP2311958A3 (de)	2011-08-10	Polynukleotide, die für antigene HIV-Polypeptide des C-Typs codieren, Polypeptide und ihre Verwendung
Esser	1988	Principles in adsorption to polystyrene
Shokat et al.	1991	Redirecting the immune response: ligand-mediated immunogenicity
KR960031602A (ko)	1996-09-17	유전자 조환에 의한 사람 인슐린 전구체의 제조 및 이를 이용한 인슐린의 제조 방법
CA2164818A1 (en)	1994-12-22	Tandem synthetic hiv-1 peptides
RU2002120486A (ru)	2004-08-20	Свободная от агрегатов уратоксидаза для приготовления неиммуногенных полимерных конъюгатов
WO2003010189A1 (en)	2003-02-06	Process for producing dipeptide, peptide synthase to be used therein and process for producing peptide synthase
EP1808180A3 (de)	2010-12-22	Modifiziertes GP 100 und Verwendung dafür
EP2460533A3 (de)	2014-01-08	Therapeutikum auf Hefebasis gegen chronische Hepatitis-C-Infection
AU2003286404A1 (en)	2004-06-30	Peptide nanostructures, methods for their preparation and use
EP2314603A3 (de)	2011-05-18	Bindungdsfaktoren von Gruppe B-Streptococcus, dafür kodierende Nukleinsäuren und Verwendungen davon
CN1030019A (zh)	1989-01-04	疫苗及其制备方法
AU3790300A (en)	2000-06-13	Methods for the preparation of nucleic acid and polypeptide libraries and uses thereof
Basava et al.	2012	Peptides: design, synthesis, and biological activity
ES2171649T3 (es)	2002-09-16	Procedimiento para la preparacion de ciclosporina cromatograficamente pura utilizando un eluyente que consta esencialmente de dioxido de carbono a alta presion.
Yoshikawa et al.	1997	Alternative molecularly imprinted polymeric membranes from a tetrapeptide residue consisting of D‐or L‐amino acids
AU6804394A (en)	1995-01-03	Oral pharmaceutical compositions comprising a protein or peptide, an antibody and polymeric beads
WO2002042426A3 (en)	2002-10-17	Carrier system for specific artery wall gene delivery
CA2521038A1 (en)	2004-10-14	Polypeptide comprising cell adhesion motif, t cell epitope and b cell epitope for inducing antibody production
EP1715046A3 (de)	2007-02-21	Polypeptid, dafür kodierende DNA, diese DNA beinhaltender, rekombinanter Vektor, Herstellung eines rekombinanten Virus unter Verwendung dieses Vektors und dessen Anwendung
AU2003264535A1 (en)	2004-04-19	Tumor antigen protein and utilization thereof
ATE412757T1 (de)	2008-11-15	Membranverankerte gp41-fusionspeptide und deren verwendungen

Legal Events

Date	Code	Title	Description
2004-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties